Is PYPD or PYXS more undervalued in 2026?

CirclFi compares PolyPid Ltd. (PYPD) and Pyxis Oncology, Inc. (PYXS) using 13 institutional-grade valuation models. PYPD has a Quality of Company score of 1.8/10 while PYXS scores 5.1/10.

Which is a better buy — PYPD or PYXS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PYPD and PYXS valuations compare?

PYPD at $4.76 and PYXS at $1.78 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PYPD vs PYXS Valuation Comparison 2026 — Intrinsic Value Analysis

PYPD

Biotechnology

PolyPid Ltd.

Quality

1.8

out of 10

Value Trap

—

Price

$4.76

Last close

Models

9/13

Active

PYXS

Biotechnology

Pyxis Oncology, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$1.78

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	PYPD Fair Value	PYPD Upside	PYXS Fair Value	PYXS Upside
Bayesian DCF	Intrinsic	$1.26	-73.5%	$0.41	-76.9%
Earnings Power Value	Intrinsic	—	—	$1.12	-34.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$26.22	+450.9%	$0.29	-83.9%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PYPD vs PYXS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PYPD vs PYXS — Which Stock Is More Undervalued?

PYXS scores higher with a 5.1/10 quality rating vs PYPD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing PolyPid Ltd. (PYPD) and Pyxis Oncology, Inc. (PYXS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PYPD currently trades at $4.76 with a QOC of 1.8/10, while PYXS trades at $1.78 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).